Correlation Between Amicus Therapeutics and Evoke Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Evoke Pharma, you can compare the effects of market volatilities on Amicus Therapeutics and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Evoke Pharma.

Diversification Opportunities for Amicus Therapeutics and Evoke Pharma

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Amicus and Evoke is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Evoke Pharma go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Evoke Pharma

Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.43 times more return on investment than Evoke Pharma. However, Amicus Therapeutics is 2.34 times less risky than Evoke Pharma. It trades about -0.33 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.26 per unit of risk. If you would invest  1,147  in Amicus Therapeutics on September 2, 2024 and sell it today you would lose (149.00) from holding Amicus Therapeutics or give up 12.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amicus Therapeutics  vs.  Evoke Pharma

 Performance 
       Timeline  
Amicus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Evoke Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Evoke Pharma disclosed solid returns over the last few months and may actually be approaching a breakup point.

Amicus Therapeutics and Evoke Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amicus Therapeutics and Evoke Pharma

The main advantage of trading using opposite Amicus Therapeutics and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.
The idea behind Amicus Therapeutics and Evoke Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges